Crystallographic study of multi-drug resistant HIV-1 protease Lopinavir complex: mechanism of drug recognition and resistance

Lopinavir (LPV) is a second generation HIV-1 protease inhibitor. Drug resistance has rapidly emerged against LPV US FDA approved it on September 15, 2000. Mutations at residues 32I, L33F, 46I, 47A, I54V, V82A, I84V and L90M render the protease drug resistant against LPV. We report the crystal struct...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biochem Biophys Res Commun
Autori principali: Liu, Zhigang, Yedidi, Ravikiran S., Wang, Yong, Dewdney, Tamaria G., Reiter, Samuel J., Brunzelle, Joseph S., Kovari, Iulia A., Kovari, Ladislau C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4520426/
https://ncbi.nlm.nih.gov/pubmed/23792096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2013.06.027
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi